FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicolas von Beckerath

Research Profile

Chemicals & Drugs

Devices

Stents

Physiology

Procedures

Disorders

Concepts & Ideas

Anatomy

Thrombosis

Co-author Network

Publications

TOP 3
Tareq Ibrahim; Sebastian Karmann; Ilka Ott; Makarios Paschalidis; Holger Poppert; Tibor Schuster; Wolfram Theiss; Corinna Böttiger; Massimiliano Fusaro; Juliane K Hilger; Nicolas von Beckerath
Safety and mid-term outcome of endovascular therapy for internal carotid artery disease: a 15-year experience at a single-centre angiology institution.
Dirk Sibbing; Arne Pfeufer; Tamara Perisic; Alexander M Mannes; Karin Fritz-Wolf; Sarah Unwin; Moritz F Sinner; Christian Gieger; Christian Johannes Gloeckner; Heinz-Erich Wichmann; Elisabeth Kremmer; Zasie Schäfer; Axel Walch; Martin Hinterseer; Michael Näbauer; Stefan Kääb; Adnan Kastrati; Albert Schömig; Thomas Meitinger; Georg W Bornkamm; Marcus Conrad; Nicolas von Beckerath
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy.
Birgit Steppich; Nicolas von Beckerath; O von Beckerath; Kathrin Schömig; S L Braun; Hans-Henning Eckstein; M Hassenpflug; Ilka Ott
Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicolas von Beckerath (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tareq Ibrahim; Sebastian Karmann; Ilka Ott; Makarios Paschalidis; Holger Poppert; Tibor Schuster; Wolfram Theiss; Corinna Böttiger; Massimiliano Fusaro; Juliane K Hilger; Nicolas von Beckerath
Safety and mid-term outcome of endovascular therapy for internal carotid artery disease: a 15-year experience at a single-centre angiology institution.
VASA. Zeitschrift für Gefässkrankheiten 2013;42(3):196-207.
2011: Dirk Sibbing; Arne Pfeufer; Tamara Perisic; Alexander M Mannes; Karin Fritz-Wolf; Sarah Unwin; Moritz F Sinner; Christian Gieger; Christian Johannes Gloeckner; Heinz-Erich Wichmann; Elisabeth Kremmer; Zasie Schäfer; Axel Walch; Martin Hinterseer; Michael Näbauer; Stefan Kääb; Adnan Kastrati; Albert Schömig; Thomas Meitinger; Georg W Bornkamm; Marcus Conrad; Nicolas von Beckerath
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy.
European heart journal 2011;32(9):1121-33.
2011: Birgit Steppich; Nicolas von Beckerath; O von Beckerath; Kathrin Schömig; S L Braun; Hans-Henning Eckstein; M Hassenpflug; Ilka Ott
Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis.
VASA. Zeitschrift für Gefässkrankheiten 2011;40(2):117-22.
2010: Isabell Bernlochner; Steven Steinhubl; Siegmund Braun; Tanja Morath; Juliane Jaitner; Julia Stegherr; Julinda Mehilli; Nicolas von Beckerath; Albert Schömig; Adnan Kastrati; Dirk Sibbing
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Thrombosis and haemostasis 2010;104(6):1193-200.
2010: Dirk Sibbing; D Gebhard; W Koch; Siegmund Braun; J Stegherr; T Morath; Nicolas von Beckerath; Julinda Mehilli; Albert Schömig; T Schuster; Adnan Kastrati
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy.
Journal of thrombosis and haemostasis : JTH 2010;8(8):1685-93.
2010: Dirk Sibbing; Nicolas von Beckerath; Tanja Morath; Julia Stegherr; Julinda Mehilli; Nikolaus Sarafoff; Siegmund Braun; Stefanie Schulz; Albert Schömig; Adnan Kastrati
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.
European heart journal 2010;31(10):1205-11.
2010: Dirk Sibbing; Julia Stegherr; Siegmund Braun; Julinda Mehilli; Stefanie Schulz; Melchior Seyfarth; Adnan Kastrati; Nicolas von Beckerath; Albert Schömig
A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment.
Journal of the American College of Cardiology 2010;55(6):558-65.
2010: Dirk Sibbing; Werner Koch; Daniela Gebhard; Tibor Schuster; Siegmund Braun; Julia Stegherr; Tanja Morath; Albert Schömig; Nicolas von Beckerath; Adnan Kastrati
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.
Circulation 2010;121(4):512-8.
2010: Dirk Sibbing; S Schulz; S Braun; T Morath; J Stegherr; J Mehilli; Albert Schömig; Nicolas von Beckerath; Adnan Kastrati
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.
Journal of thrombosis and haemostasis : JTH 2010;8(2):250-6.
2010: Iris I Mueller; Dagmar Steiner; Nicolas von Beckerath; Klaus Altland; Meinrad Gawaz; Reinhold P Linke; Christine Zuern; Hans-Joerg Weig
Restrictive cardiomyopathy in inherited ATTR amyloidosis (TTR-Ser23Asn) in a patient of German-Italian extraction.
BMJ case reports 2010;2010():.
2010: Christian Schulz; Olga von Beckerath; Rainer Okrojek; Nicolas von Beckerath; Steffen Massberg
Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin.
Thrombosis journal 2010;8():13.
2010: Dirk Sibbing; Tanja Morath; Siegmund Braun; Julia Stegherr; Julinda Mehilli; Wolfgang Vogt; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
Thrombosis and haemostasis 2010;103(1):151-9.
2010: Nicolas von Beckerath; Dirk Sibbing; Stefan Jawansky; Siegmund Braun; Tanja Morath; Wolfgang Vogt; Albert Schömig; Adnan Kastrati
Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(1):46-52.
2009: Siegmund Braun; Nicolas von Beckerath; Julia Ellert; Adnan Kastrati; Albert Schömig; Wolfgang Vogt; Dirk Sibbing
Assessment of platelet function in whole blood by multiple electrode aggregometry: transport of samples using a pneumatic tube system.
American journal of clinical pathology 2009;132(5):802-3; author reply 803-4.
2009: Nikolaus Sarafoff; Dorothee Maria Baur; Jochen Gaa; Nicolas von Beckerath
Images in cardiovascular medicine. Recurrent syncope due to torsades de pointes in a 41-year-old woman with an empty sella, anterior pituitary insufficiency, and a long-QT interval.
Circulation 2009;120(14):e127-9.
2009: Dirk Sibbing; Tanja Morath; Julia Stegherr; Siegmund Braun; Wolfgang Vogt; Martin Hadamitzky; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Thrombosis and haemostasis 2009;101(4):714-9.
2009: Dirk Sibbing; Julia Stegherr; Wolfgang Latz; Werner Koch; Julinda Mehilli; Katharina Dörrler; Tanja Morath; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.
European heart journal 2009;30(8):916-22.
2009: Dirk Sibbing; Siegmund Braun; Tanja Morath; Julinda Mehilli; Wolfgang Vogt; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Journal of the American College of Cardiology 2009;53(10):849-56.
2009: Gabriele Busch; Birgit Steppich; Dirk Sibbing; Siegmund-Lorenz Braun; Andreas Stein; Philipp Groha; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath; Ilka Ott
Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention.
Thrombosis and haemostasis 2009;101(2):340-4.
2009: Birgit Steppich; Siegmund Lorenz Braun; Andreas Stein; Gabriele Demetz; Philip Groha; Albert Schömig; Nicolas von Beckerath; Adnan Kastrati; Ilka Ott
Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction.
Thrombosis journal 2009;7():11.
2008: Olga von Beckerath; Jochen Gaa; Christoph Winkler von Mohrenfels; Nicolas von Beckerath
Images in cardiovascular medicine. Intermittent claudication in a 28-year-old man with pseudoxanthoma elasticum.
Circulation 2008;118(1):102-4.
2008: Dirk Sibbing; Dirk Taubert; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Pharmacokinetics of clopidogrel in patients with stent thrombosis.
Journal of thrombosis and haemostasis : JTH 2008;6(7):1230-2.
2008: Dirk Sibbing; Gabriele Busch; Siegmund Braun; Stefan Jawansky; Albert Schömig; Adnan Kastrati; Ilka Ott; Nicolas von Beckerath
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention.
European heart journal 2008;29(12):1504-9.
2008: Christian Von Bary; Thomas Liebig; Jochen Gaa; Nicolas von Beckerath
Ischaemic stroke and myocardial infarction in a Caucasian patient with Moya-Moya disease.
European heart journal 2008;29(7):842.
2008: Antonius A C M Heestermans; Jochem W van Werkum; Dirk Taubert; Toine H Seesing; Nicolas von Beckerath; Christian M Hackeng; Edgar Schömig; F W A Verheugt; Jurriën M ten Berg
Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction.
Thrombosis research 2008;122(6):776-81.
2008: Dirk Sibbing; Siegmund Braun; Stefan Jawansky; Wolfgang Vogt; Julinda Mehilli; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment.
Thrombosis and haemostasis 2008;99(1):121-6.
2007: Nicolas von Beckerath; Adnan Kastrati; Anna Wieczorek; Gisela Pogatsa-Murray; Dirk Sibbing; Isolde Graf; Albert Schömig
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.
European heart journal 2007;28(15):1814-9.
2007: Dirk Sibbing; Olga von Beckerath; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention.
The American journal of cardiology 2007;100(2):203-5.
2007: Dirk Sibbing; Olga von Beckerath; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Platelet function in clopidogrel-treated patients with acute coronary syndrome.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(4):335-9.
2007: Klaus Tiroch; Werner Koch; Nicolas von Beckerath; Adnan Kastrati; Albert Schömig
Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting.
European heart journal 2007;28(8):968-73.
2006: Dirk Sibbing; Olga von Beckerath; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2566-8.
2006: Dirk Taubert; Nicolas von Beckerath; Gundula Grimberg; Andreas Lazar; Norma Jung; Tobias Goeser; Adnan Kastrati; Albert Schömig; Edgar Schömig
Impact of P-glycoprotein on clopidogrel absorption.
Clinical pharmacology and therapeutics 2006;80(5):486-501.
2006: Nicolas von Beckerath; Gisela Pogatsa-Murray; Anna Wieczorek; Dirk Sibbing; Albert Schömig; Adnan Kastrati
Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness.
Thrombosis and haemostasis 2006;95(5):910-1.
2006: Gjin Ndrepepa; Siegmund Braun; Julinda Mehilli; Nicolas von Beckerath; Stephan Nekolla; Wolfgang Vogt; Markus Schwaiger; Albert Schömig; Adnan Kastrati
N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis.
The American journal of cardiology 2006;97(8):1151-6.
2006: Dirk Sibbing; Olga von Beckerath; Albert Schömig; Adnan Kastrati; Nicolas von Beckerath
P2Y1 gene A1622G dimorphism is not associated with adenosine diphosphate-induced platelet activation and aggregation after administration of a single high dose of clopidogrel.
Journal of thrombosis and haemostasis : JTH 2006;4(4):912-4.
2006: Gjin Ndrepepa; Adnan Kastrati; Siegmund Braun; Julinda Mehilli; Kathrin Niemöller; Nicolas von Beckerath; Olga von Beckerath; Wolfgang Vogt; Albert Schömig
N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
The American journal of medicine 2006;119(4):355.e1-8.
2005: Nicolas von Beckerath; Dirk Taubert; Gisela Pogatsa-Murray; Edgar Schömig; Adnan Kastrati; Albert Schömig
Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
Circulation 2005;112(19):2946-50.
2005: Gjin Ndrepepa; Siegmund Braun; Kathrin Niemöller; Julinda Mehilli; Nicolas von Beckerath; Olga von Beckerath; Wolfgang Vogt; Albert Schömig; Adnan Kastrati
Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina.
Circulation 2005;112(14):2102-7.
2005: Dirk Sibbing; Olga von Beckerath; Nicolas von Beckerath; Werner Koch; Julinda Mehilli; Markus Schwaiger; Albert Schömig; Adnan Kastrati
Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(7):511-5.
2005: Gjin Ndrepepa; Siegmund Braun; Nicolas von Beckerath; Julinda Mehilli; Olga Gorchakova; Wolfgang Vogt; Albert Schömig; Adnan Kastrati
Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.
Clinica chimica acta; international journal of clinical chemistry 2005;360(1-2):178-86.
2005: Siegmund Braun; Gjin Ndrepepa; Nicolas von Beckerath; Julinda Mehilli; Olga Gorchakova; Wolfgang Vogt; Albert Schömig; Adnan Kastrati
Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.
American heart journal 2005;150(3):550-6.
2005: Klaus Tiroch; Nicolas von Beckerath; Werner Koch; J Lengdobler; Alexander Joost; Albert Schömig; Adnan Kastrati
Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting.
Atherosclerosis 2005;182(1):145-51.
2005: Alban Dibra; Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Helmut Schühlen; Nicolas von Beckerath; Kurt Ulm; Rainer Wessely; Josef Dirschinger; Albert Schömig
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
The New England journal of medicine 2005;353(7):663-70.
2005: Nicolas von Beckerath; Dirk Taubert; Gisela Pogatsa-Murray; Anna Wieczorek; Edgar Schömig; Albert Schömig; Adnan Kastrati
A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite.
Thrombosis and haemostasis 2005;93(4):789-91.
2005: Nicolas von Beckerath; Olga von Beckerath; Werner Koch; Marianne Eichinger; Albert Schömig; Adnan Kastrati
P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(3):199-204.
2005: Gjin Ndrepepa; Siegmund Braun; Julinda Mehilli; Nicolas von Beckerath; Wolfgang Vogt; Albert Schömig; Adnan Kastrati
Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
The American journal of cardiology 2005;95(5):553-7.
2005: Adnan Kastrati; Julinda Mehilli; Nicolas von Beckerath; Alban Dibra; Jörg Hausleiter; Jürgen Pache; Helmut Schühlen; Claus Schmitt; Josef Dirschinger; Albert Schömig
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;293(2):165-71.
2004: Julinda Mehilli; Adnan Kastrati; Helmut Schühlen; Alban Dibra; Franz Dotzer; Nicolas von Beckerath; Hildegard Bollwein; Jürgen Pache; Josef Dirschinger; Peter P Berger; Albert Schömig
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
Circulation 2004;110(24):3627-35.
2004: Olga Gorchakova; Nicolas von Beckerath; Meinrad Gawaz; Adrienne Mocz; Alexander Joost; Albert Schömig; Adnan Kastrati
Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting.
European heart journal 2004;25(21):1898-902.
2004: Ilka Ott; Werner Koch; Nicolas von Beckerath; Rene de Waha; Anna Malawaniec; Julinda Mehilli; Albert Schömig; Adnan Kastrati
Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction.
Atherosclerosis 2004;177(1):189-91.
2004: Adnan Kastrati; Nicolas von Beckerath; Alexander Joost; Gisela Pogatsa-Murray; Olga Gorchakova; Albert Schömig
Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.
Circulation 2004;110(14):1916-9.
2004: Jürgen Schreieck; Stefan Dostal; Nicolas von Beckerath; Annette Wacker; Michelle Flory; Sonja Weyerbrock; Werner Koch; Albert Schömig; Claus Schmitt
C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation.
American heart journal 2004;148(3):545-50.
2004: Dirk Taubert; Adnan Kastrati; Steffi Harlfinger; Olga Gorchakova; Andreas Lazar; Nicolas von Beckerath; Albert Schömig; Edgar Schömig
Pharmacokinetics of clopidogrel after administration of a high loading dose.
Thrombosis and haemostasis 2004;92(2):311-6.
2004: Siegmund Braun; Gjin Ndrepepa; Nicolas von Beckerath; Wolfgang Vogt; Albert Schömig; Adnan Kastrati
Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations.
Atherosclerosis 2004;174(1):105-10.
2004: Julinda Mehilli; Adnan Kastrati; Josef Dirschinger; Lena Etzel; Hildegard Bollwein; Jürgen Pache; Helmut Schühlen; Nicolas von Beckerath; Melchior Seyfarth; Claus Schmitt; Albert Schömig
Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial).
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2004;61(2):190-5.
2004: Nicolas von Beckerath; Werner Koch; Julinda Mehilli; Olga Gorchakova; Siegmund Braun; Albert Schömig; Adnan Kastrati
ABO locus O1 allele and risk of myocardial infarction.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(1):61-7.
2004: Olga Gorchakova; Werner Koch; Julinda Mehilli; Nicolas von Beckerath; Markus Schwaiger; Albert Schömig; Adnan Kastrati
PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction.
Thrombosis and haemostasis 2004;91(1):141-5.
2003: Werner Koch; Klaus Tiroch; Nicolas von Beckerath; Albert Schömig; Adnan Kastrati
Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.
Cytokine 2003;24(4):161-71.
2003: Corinna Böttiger; Werner Koch; Christina Lahn; Julinda Mehilli; Nicolas von Beckerath; Albert Schömig; Adnan Kastrati
4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
American heart journal 2003;146(5):855-61.
2003: Werner Koch; Julinda Mehilli; Nicolas von Beckerath; Corinna Böttiger; Albert Schömig; Adnan Kastrati
Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
Journal of the American College of Cardiology 2003;41(11):1957-61.
2003: Olga Gorchakova; Werner Koch; Nicolas von Beckerath; Julinda Mehilli; Albert Schömig; Adnan Kastrati
Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement.
European heart journal 2003;24(9):820-7.
2003: Nicolas von Beckerath; Yasmin Schusterschitz; Werner Koch; Korinna Griesser; Julinda Mehilli; Olga Gorchakova; Albert Schömig; Adnan Kastrati
G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease.
Atherosclerosis 2003;167(1):135-9.
2002: Werner Koch; Adnan Kastrati; Julinda Mehilli; Nicolas von Beckerath; Albert Schömig
CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction.
American heart journal 2002;143(6):971-6.
2001: Werner Koch; Corinna Böttiger; Julinda Mehilli; Nicolas von Beckerath; F J Neumann; Albert Schömig; Adnan Kastrati
Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.
The American journal of cardiology 2001;88(10):1120-4.
2001: Werner Koch; Adnan Kastrati; Corinna Böttiger; Julinda Mehilli; Nicolas von Beckerath; Albert Schömig
Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction.
Atherosclerosis 2001;159(1):137-44.
2001: Nicolas von Beckerath; Werner Koch; Julinda Mehilli; Corinna Böttiger; S Braun; Albert Schömig; Adnan Kastrati
Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting.
Atherosclerosis 2001;156(2):463-8.
2000: Adnan Kastrati; Werner Koch; P B Berger; Julinda Mehilli; K Stephenson; F J Neumann; Nicolas von Beckerath; Corinna Böttiger; G W Duff; Albert Schömig
Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting.
Journal of the American College of Cardiology 2000;36(7):2168-73.
2000: Werner Koch; Adnan Kastrati; Julinda Mehilli; Corinna Böttiger; Nicolas von Beckerath; Albert Schömig
Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
Circulation 2000;102(2):197-202.
2000: Adnan Kastrati; Werner Koch; Meinrad Gawaz; Julinda Mehilli; Corinna Böttiger; Kathrin Schömig; Nicolas von Beckerath; Albert Schömig
PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
Journal of the American College of Cardiology 2000;36(1):84-9.
2000: Nicolas von Beckerath; Werner Koch; Julinda Mehilli; Corinna Böttiger; Albert Schömig; Adnan Kastrati
Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting.
Blood 2000;95(11):3297-301.
2000: Corinna Böttiger; Adnan Kastrati; Werner Koch; Julinda Mehilli; H Seidl; Kathrin Schömig; Nicolas von Beckerath; Albert Schömig
HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction.
Thrombosis and haemostasis 2000;83(4):559-62.
2000: Nicolas von Beckerath; Adnan Kastrati; Werner Koch; Corinna Böttiger; Julinda Mehilli; Melchior Seyfarth; Albert Schömig
G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement.
Atherosclerosis 2000;149(1):151-5.
1999: Corinna Böttiger; Adnan Kastrati; Werner Koch; Julinda Mehilli; Nicolas von Beckerath; Josef Dirschinger; Meinrad Gawaz; Albert Schömig
Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement.
The American journal of cardiology 1999;84(9):987-91.
1999: Adnan Kastrati; Albert Schömig; Melchior Seyfarth; Werner Koch; Shpend Elezi; Corinna Böttiger; Julinda Mehilli; Kathrin Schömig; Nicolas von Beckerath
PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.
Circulation 1999;99(8):1005-10.